Mersana Therapeutics
MRSN
MRSN
109 hedge funds and large institutions have $647M invested in Mersana Therapeutics in 2021 Q3 according to their latest regulatory filings, with 11 funds opening new positions, 45 increasing their positions, 34 reducing their positions, and 32 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less ownership
Funds ownership: →
less funds holding
Funds holding: →
less call options, than puts
Call options by funds: $ | Put options by funds: $
32% less capital invested
Capital invested by funds: $955M → $647M (-$308M)
33% less funds holding in top 10
Funds holding in top 10: 3 → 2 (-1)
66% less first-time investments, than exits
New positions opened: 11 | Existing positions closed: 32
Holders
109
Holding in Top 10
2
Calls
$1.22M
Puts
$1.57M
Top Buyers
| 1 | +$12.4M | |
| 2 | +$7.96M | |
| 3 | +$5.36M | |
| 4 |
Morgan Stanley
New York
|
+$5.11M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$4.72M |
Top Sellers
| 1 | -$28.6M | |
| 2 | -$12.6M | |
| 3 | -$8.2M | |
| 4 |
GTC
Ghost Tree Capital
New York
|
-$6.11M |
| 5 |
CC
Commodore Capital
New York
|
-$5.83M |